Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2007
09/05/2007EP1829888A1 Anti-inflammatory compounds and uses thereof
09/05/2007EP1829536A1 Ameliorant for renal insufficiency
09/05/2007EP1829529A1 Controlled release compositions of estradiol metabolites
09/05/2007EP1828122A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
09/05/2007EP1828121A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
09/05/2007EP1827420A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
09/05/2007EP1827386A2 Oral compositions for absorption of phosphorus compounds
09/05/2007EP1406892B1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1036566B1 Preparation for continuous intravenous administration
09/05/2007CN200942189Y Point therapeutic medicine sticker for prostatitis
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/05/2007CN101028473A Chinese medicine for treating bed-wetting disease and its production
09/05/2007CN101028455A Oral Chinese-medicinal composition for treating urinary-tract infection
09/05/2007CN101028421A Chinese medicine for treating chronic kidney failure
09/05/2007CN101028419A Chinese-medicinal preparation for treating nongonococcal urethritis
09/05/2007CN101028391A Chinese medicine for treating urinary system infection
09/05/2007CN101028387A Oral solid preparation for treating chronic prostatic phlogosis and its production
09/05/2007CN101028349A Externally-applied medicine for treating prostatitis and prostatic accrementition
09/05/2007CN101028345A Chinese medicine for treating acute and chronic nephritis
09/05/2007CN101028336A Medicinal composition containing lamiophlomis and Touhualiao
09/05/2007CN101028317A Use of hypericum japonicum in preparation of medicine against nephritis and renal insufficiency
09/05/2007CN101028282A Use of low-molecular weight phaeophytin polyose sulfate in preparation of medicine for treating kidney disease
09/05/2007CN100335481C Poly-substituted pyridino-[4,3d] pyramine with antibacterial and herbicide activity and its production thereof
09/05/2007CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/05/2007CN100335123C Method for improving oral drug living thing availability, composition and reagent box
09/05/2007CN100335105C Manufacturing method of cordyceps root securing promoting blood medicine
09/05/2007CN100335057C Tablet with controlled release of alfuzosine chlorhydrate
09/04/2007US7265260 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/04/2007US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity
09/04/2007US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
09/04/2007US7265157 Sustained release compositions, process for producing the same and use thereof
09/04/2007US7265143 C-4 substituted retinoids
09/04/2007US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
09/04/2007US7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
09/04/2007US7265119 For therapy of nicotine dependency
09/04/2007US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis
09/04/2007US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
09/04/2007CA2297911C Substituted 6-phenylphenanthridines
08/2007
08/30/2007WO2007098386A1 Pyrazolylquinazolinones as potassium channel openers
08/30/2007WO2007097358A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/30/2007WO2007097289A1 Novel pharmaceutical
08/30/2007US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
08/30/2007US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
08/30/2007US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/30/2007US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
08/30/2007US20070203141 Method for administering birb 796 bs
08/30/2007US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors
08/30/2007US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors
08/30/2007US20070202160 Solid-state form of celecoxib having enhanced bioavailability
08/30/2007CA2642832A1 Pyrazolylquinazolinones as potassium channel openers
08/30/2007CA2638122A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/29/2007EP1826207A1 Acid salt of benzimidazole derivative and crystal thereof
08/29/2007EP1824860A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
08/29/2007EP1824851A2 Novel diazabicyclononene derivative
08/29/2007EP1824487A1 The use of 4-(s)-(4-acetyl-piperazin-1-yl)-2-(r)-(4-fluoro-2-methyl-phenyl)-piperidine-1-carboxilic acid, [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide for the treatment of overactive bladder
08/29/2007EP1506167B1 Hydroxy tetrahydro-naphthalenylurea derivatives
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker
08/29/2007CN101027052A Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction
08/29/2007CN101024057A Chinese medicine for treating infant's enuresis
08/29/2007CN101024054A Oral Chinese medicine composition for treating glandular cystitis
08/29/2007CN101024053A Chinese medicine for treating chronic kidney disease
08/29/2007CN101024007A Micro-emulsion injecta containing houttuynia extract
08/29/2007CN101024006A Chinese medicine for treating gallstones
08/29/2007CN101023803A Chinese wolf-berry pumpkin drink
08/29/2007CN101023758A Method for preparing crisp cake
08/29/2007CN100334109C GLP-1 analogues
08/29/2007CN100334077C Benzimidazole derivatives and their use as GNRH antagonists
08/29/2007CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands
08/29/2007CN100333741C Medicine for preventing and treating diabets and kidney disease and preparing method
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/28/2007US7262302 Antiinflammatory action; rheumatoid arthritis
08/28/2007US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof
08/28/2007US7262201 Quinazoline derivatives
08/28/2007US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/28/2007CA2294515C Eprosartan monohydrate
08/23/2007WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007WO2007093611A1 Fixed-dose association of phytate and zinc
08/23/2007WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
08/23/2007WO2007066068A3 Calcium ion channel receptor antagonist
08/23/2007WO2007010552B1 N- terminal peg conjugate of erythropoietin
08/23/2007US20070197666 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
08/23/2007US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
08/23/2007US20070197602 Combined pharmaceutical composition
08/23/2007US20070197570 Indanol derivative
08/23/2007US20070197562 Remedies for prostatic hypertrophy
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient
08/23/2007DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists
08/23/2007CA2645734A1 Method of treating inflammatory diseases
08/23/2007CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007CA2641216A1 Fixed-dose association of phytate and zinc
08/22/2007EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition
08/22/2007EP1820507A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them